Prognostic Impact of Inflammatory Biomarkers in Diffuse Large B-Cell Lymphoma: Analysis of a Cohort of 76 Patients

Authors

  • Zaineb Mlayah Department of Clinical Hematology,Hospital Fattouma Bourguiba, Faculty of Medicine of Monastir, University of Monastir, 5000, Monastir, Tunisia.
  • Ons Charef Department of Clinical Hematology,Hospital Fattouma Bourguiba, Faculty of Medicine of Monastir, University of Monastir, 5000, Monastir, Tunisia.
  • Yasmine Bnouni Department of Clinical Hematology,Hospital Fattouma Bourguiba, Faculty of Medicine of Monastir, University of Monastir, 5000, Monastir, Tunisia.
  • Nada Mabrouk Department of Oncology, Hospital Fattouma Bourguiba, Faculty of Medicine of Monastir, University of Monastir, 5000, Monastir, Tunisia.
  • Ines Ben Rekaya Department of Clinical Hematology,Hospital Fattouma Bourguiba, Faculty of Medicine of Monastir, University of Monastir, 5000, Monastir, Tunisia.
  • Inaam Bizid Department of Clinical Hematology,Hospital Fattouma Bourguiba, Faculty of Medicine of Monastir, University of Monastir, 5000, Monastir, Tunisia.
  • Nader Slama Department of Clinical Hematology,Hospital Fattouma Bourguiba, Faculty of Medicine of Monastir, University of Monastir, 5000, Monastir, Tunisia.
  • Sara Boukhris Department of Clinical Hematology,Hospital Fattouma Bourguiba, Faculty of Medicine of Monastir, University of Monastir, 5000, Monastir, Tunisia.
  • Mohamed-Adnene Laatiri Department of Clinical Hematology,Hospital Fattouma Bourguiba, Faculty of Medicine of Monastir, University of Monastir, 5000, Monastir, Tunisia.

DOI:

https://doi.org/10.62438/tunismed.v104i08.5946

Keywords:

Diffuse large B-cell lymphoma, Prognosis, Inflammation, Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio, Systemic immune-inflammation index

Abstract

Introduction: Inflammation plays a key role in the progression of diffuse large B-cell lymphoma (DLBCL). Biomarkers such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) have been associated with prognosis in various malignancies. This study evaluates their prognostic impact in DLBCL.
Methods: We retrospectively analyzed 76 patients diagnosed with DLBCL. NLR, PLR, and SII were calculated before treatment. Associations with clinical and biological parameters were assessed using univariate analysis (Chi-square test). A multivariate analysis was performed using Cox regression to determine independent prognostic factors.
Results: Elevated PLR was significantly associated with higher performance status (PS) and increased lactate dehydrogenase (LDH) levels, which are known poor prognostic factors in DLBCL. However, in multivariate Cox regression analysis, PLR was not identified as an independent prognostic factor for survival. NLR and SII showed trends toward similar associations but did not reach statistical significance.
Conclusion: While PLR correlates with key clinical and biological indicators of disease severity, it does not appear to be an independent prognostic factor in DLBCL. Further studies with larger cohorts are needed to clarify its prognostic value.

Downloads

Download data is not yet available.

References

Zhou D, Wu Y, Zhu Y, Lin Z, Yu D, Zhang T. The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Monocyte-to-lymphocyte

Ratio in Metastatic Gastric Cancer Treated with Systemic Chemotherapy. J Cancer. 2020;11(14):4205-12.

Bauzá Quetglas JL, Tienza Fernández A, Bertolo R, Sabaté Arroyo XA, Guimerà García J, Tubau Vidaña V, et al. The prognostic value

of the neutrophil-to-lymphocyte ratio in patients with testicular cancer. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol.

avr 2020;30(5):273-80.

Go SI, Park S, Kim JH, Kim HR, Kim M, Moon K, et al. A new prognostic model using the NCCN-IPI and neutrophil-to-lymphocyte ratio in

diffuse large B-cell lymphoma. Tumori. août 2018;104(4):292-9.

Wang Y, Hu X, Su MC, Wang YW, Che GW. Postoperative Elevations of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios

Predict Postoperative Pulmonary Complications in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study. Curr Med Sci.

avr 2020;40(2):339-47.

Zhang J, Zhang HY, Li J, Shao XY, Zhang CX. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal

cancer: a systematic review and meta-analysis. Oncotarget. 15 sept 2017;8(40):68837-46.

Portale G, Cavallin F, Valdegamberi A, Frigo F, Fiscon V. Platelet- to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are

Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection. J Gastrointest Surg Off J Soc Surg Aliment Tract. sept

;22(9):1611-8.

Miklikova S, Minarik G, Sedlackova T, Plava J, Cihova M, Jurisova S, et al. Inflammation-Based Scores Increase the Prognostic Value

of Circulating Tumor Cells in Primary Breast Cancer. Cancers. 1 mai 2020;12(5):1134.

Zhan H, Ma JY, Jian QC. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-

analysis. Clin Chim Acta Int J Clin Chem. sept 2018;484:136-40.

Davoodzadeh Gholami M, Kardar GA, Saeedi Y, Heydari S, Garssen J, Falak R. Exhaustion of T lymphocytes in the tumor

microenvironment: Significance and effective mechanisms. Cell Immunol. déc 2017;322:1-14.

Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, et al. T helper 17 cells promote cytotoxic T cell activation in tumor

immunity. Immunity. 20 nov 2009;31(5):787-98.

Li Y, Zhu Y, Duan X. Prognostic value of multiple immune inflammatory markers in diffuse large B-cell lymphoma. Am J Transl

Res. 15 avr 2023;15(4):2610-21.

Azuma Y, Nakaya A, Fujita S, Satake A, Nakanishi T, Tsubokura Y, et al. Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome

of diffuse large B cell lymphoma. Leuk Res Rep. 2019;12:100173.

Hasan KM, Elmeshhedany AY. Prognostic value of absolute lymphocyte/monocyte ratio, red cell distribution width and

neutrophil/ lymphocyte ratio in diffuse large B-cell lymphoma patients. Cell Mol Biol Noisy--Gd Fr. 25 nov 2021;67(3):61-8.

Zhao Z, Zhao X, Lu J, Xue J, Liu P, Mao H. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio

in ovarian cancer: a meta-analysis of retrospective studies. Arch Gynecol Obstet. avr 2018;297(4):849-57.

Gao F, Hu J, Zhang J, Xu Y. Prognostic Value of Peripheral Blood Lymphocyte/monocyte Ratio in Lymphoma. J Cancer. 19 avr

;12(12):3407-17.

Chen Y, Zhang Z, Fang Q, Jian H. Prognostic impact of platelet-to- lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis. Cancer Cell Int. 24 sept 2019;19:245.

Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, et al. Systemic Immune-Inflammation Index (SII) Predicts Poor

Survival in Pancreatic Cancer Patients Undergoing Resection. J Gastrointest Surg. 2020;24(3):610-8.

Chen L, Kong X, Wang Z, Wang X, Fang Y, Wang J. Pre-treatment systemic immune-inflammation index is a useful prognostic

indicator in patients with breast cancer undergoing neoadjuvant chemotherapy. J Cell Mol Med. mars 2020;24(5):2993-3021.

Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. Systemic immune- inflammation index predicting chemoradiation resistance and

poor outcome in patients with stage III non-small cell lung cancer. J Transl Med. 31 oct 2017;15:221.

Yatabe S, Eto K, Haruki K, Shiba H, Kosuge M, Ohkuma M, et al. Signification of Systemic Immune-Inflammation Index for prediction

of prognosis after resecting in patients with colorectal cancer. Int J Colorectal Dis. août 2020;35(8):1549-55.

Wang Z, Zhang J, Luo S, Zhao X. Prognostic Significance of Systemic Immune-Inflammation Index in Patients With Diffuse Large B-Cell Lymphoma. Front Oncol. 26 mai 2021;11:655259.

Fan Z, Shou L. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse

large B-cell lymphoma: a meta-analysis. Ther Adv Hematol. 10 nov 2023;14:20406207231208973.

Additional Files

Published

2026-09-13

Issue

Vol. 104 No. 08 (2026): Tunis Med Aug 2026

Section

Original articles

License

Copyright (c) 2026 La Tunisie Médicale

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.